Baird Downgrades Tandem Diabetes Care (TNDM) to Neutral
- Wall Street falls ahead of inauguration
- IBM (IBM) Tops Q4 EPS by 13c, FY17 EPS Guidance Beats Consensus
- American Express (AXP) Misses Q4 EPS by 7c, FY17 EPS Guidance Tops Views at Mid-Poinit
- Skyworks Solutions (SWKS) Tops Q1 EPS by 3c, Offers Q2 Guidance, Announces Buyback
- Synergy Pharma (SGYP) Trulance (Plecanatide) Approved by FDA
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Baird downgraded Tandem Diabetes Care (NASDAQ: TNDM) from Outperform to Neutral with a price target of $4.00 (from $11.00).
Shares of Tandem Diabetes Care closed at $5.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Roth Capital Downgrades Ideal Power (IPWR) to Neutral
- Netflix (NFLX) PT Raised to $150.00 at BMO Capital; Keeps 'Market Perform'
- Cowen Downgrades Patterson-UTI Energy (PTEN) to Market Perform
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesRobert W Baird
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!